| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |